tradingkey.logo

Inmode Ltd

INMD
View Detailed Chart

13.740USD

+0.080+0.59%
Close 08/01, 16:00ETQuotes delayed by 15 min
868.49MMarket Cap
4.94P/E TTM

Inmode Ltd

13.740

+0.080+0.59%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.59%

5 Days

-6.66%

1 Month

-9.37%

6 Months

-17.58%

Year to Date

-17.72%

1 Year

-19.93%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts
HOLD
Current Rating
16.250
Target Price
18.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

95
Total
4
Median
7
Average
Company name
Ratings
Analysts
Inmode Ltd
INMD
7
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Strong sell
Sell(11)
Neutral(1)
Buy(0)
Indicators
Sell(5)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.191
Sell
RSI(14)
40.453
Neutral
STOCH(KDJ)(9,3,3)
22.298
Sell
ATR(14)
0.393
Low Volatility
CCI(14)
-142.924
Sell
Williams %R
77.854
Sell
TRIX(12,20)
-0.062
Sell
StochRSI(14)
12.339
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
14.030
Sell
MA10
14.270
Sell
MA20
14.476
Sell
MA50
14.327
Sell
MA100
15.195
Sell
MA200
16.602
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMr. Moshe Mizrahy
Websitehttps://inmodemd.com/
KeyAI